Skip to main content
Home
FULL MENU Close Menu
Home
Home

HT Staff

News

Team recommends melanoma screening in CLL

Author:
HT Staff
Publish date: August 10, 2018

Patients with chronic lymphocytic leukemia (CLL) should be routinely monitored for melanoma, according to researchers. A study of 470 CLL patients...

  • Read More

News

Frequent BCCs linked to blood cancers

Author:
HT Staff
Publish date: August 9, 2018

New research suggests people who develop frequent cases of basal cell carcinoma (BCC) have an increased risk of leukemias, lymphomas, and other...

  • Read More

News

Comprehensive sequencing informs treatment for MM

Author:
HT Staff
Publish date: August 9, 2018

A comprehensive RNA and DNA sequencing platform can guide treatment decisions for late-stage and drug-resistant multiple myeloma (MM), according...

  • Read More

News

Tool identifies potential treatment for resistant MM

Author:
HT Staff
Publish date: August 9, 2018

Researchers say they have developed a computational platform that can be used to identify optimal treatments for multiple myeloma (MM). Using...

  • Read More

News

FDA approves mogamulizumab for MF, SS

Author:
HT Staff
Publish date: August 8, 2018

The US Food and Drug Administration (FDA) has approved mogamulizumab-kpkc (Poteligeo®) for the treatment of adults with relapsed or refractory...

  • Read More

News

Health Canada approves emicizumab

Author:
HT Staff
Publish date: August 8, 2018

Health Canada has approved emicizumab (Hemlibra®) for use as routine prophylaxis to prevent or reduce bleeding episodes in hemophilia A patients...

  • Read More

News

Drug could be repurposed for T-ALL

Author:
HT Staff
Publish date: August 8, 2018

Venetoclax might improve the treatment of certain patients with T-cell acute lymphoblastic leukemia (T-ALL), according to preclinical research...

  • Read More

News

FDA grants fast track designation to dilanubicel

Author:
HT Staff
Publish date: August 8, 2018

The US Food and Drug Administration (FDA) has granted fast track designation to dilanubicel (NLA101) for use in patients with high-risk...

  • Read More

News

A new way to expand HSCs for UCB transplant

Author:
HT Staff
Publish date: August 7, 2018

Researchers say they have discovered a new approach to expand hematopoietic stem cells (HSCs) from umbilical cord blood (UCB). The team...

  • Read More

News

Treatment guidelines for CAR T-cell therapy

Author:
HT Staff
Publish date: August 7, 2018

Researchers have developed treatment guidelines for pediatric patients receiving chimeric antigen receptor (CAR) T-cell therapy. The guidelines...

  • Read More

News

FDA advises against azithromycin use in allo-HSCT recipients

Author:
HT Staff
Publish date: August 7, 2018

The US Food and Drug Administration (FDA) is warning against long-term use of azithromycin (Zithromax, Zmax) in patients who undergo allogeneic...

  • Read More

News

Company stops development of drug for MM

Author:
HT Staff
Publish date: August 6, 2018

MorphoSys AG has decided to stop developing MOR202 as a treatment for multiple myeloma (MM). However, MorphoSys said it will complete the ongoing...

  • Read More

News

Company narrows focus of development for tazemetostat

Author:
HT Staff
Publish date: August 5, 2018

Epizyme, Inc., has announced its decision to stop developing tazemetostat for use as monotherapy or in combination with prednisolone for patients...

  • Read More

News

Orphan designation recommended for PCM-075

Author:
HT Staff
Publish date: August 4, 2018

The European Medicines Agency’s Committee for Orphan Medicinal Products (COMP) has recommended that PCM-075 receive orphan drug designation as a...

  • Read More

News

Work explains link between hypoxia and thrombosis

Author:
HT Staff
Publish date: August 3, 2018

Researchers say they have discovered how hypoxia increases the risk of thrombosis. The team noted that the cellular response to hypoxia is...

  • Read More

Pages

  • « first
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close